Research and Development

Showing 15 posts of 9599 posts found.

Boehringer’s lung cancer candidate enters phase III

August 5, 2009 Research and Development, Sales and Marketing Boehringer, Cancer

Boehringer Ingelheim is to enter phase III studies with a candidate to treat a subset of patients with non-small cell …

ICR conference moves to London

August 4, 2009 Business Services, Research and Development Conference, ICR

The Institute of Clinical Research (ICR) is to hold its next annual spring conference and exhibition on 19-20 April at …

Covance lifted by $145m Merck deal

August 4, 2009 Research and Development CRO, Covance

Covance's late-stage development services unit helped the contract research organisation to a 7% increase in second quarter net revenues, ahead …

Avastin gets US approval in kidney cancer

August 4, 2009 Research and Development, Sales and Marketing Roche, US, avastin

Roche's rising star Avastin has won US approval to treat the most common type of kidney cancer, the latest in …

UCB in ‘dynamic mode’ as work begins at new biologics research centre

July 31, 2009 Research and Development UCB, biologics

 UCB has opened its new biologics research centre in the UK, marking an investment of £25 million for the growing …

Reshuffle at the top as Mylan deals with quality queries

July 31, 2009 Manufacturing and Production, Research and Development Mylan

US pharmaceutical firm Mylan has promoted chief operating officer Heather Bresch to the post of president as it rides a …

Merck Serono asks EMEA to re-think Erbitux rejection

July 30, 2009 Research and Development, Sales and Marketing Cancer, EMEA, Erbitux, Europe, Merck Serono

Merck Serono is to appeal against the European rejection of Erbitux as a lung cancer treatment.Erbitux has been rejected as …

Synexus expands

July 30, 2009 Research and Development CRO, Synexus

CRO Synexus has doubled its head office capacity as it continues to grow across the UK, Central and Eastern Europe, …

Contract research news in brief

July 28, 2009 Research and Development CRO

The first crop of second-quarter figures from the contract research sector reveals a mixed bag, with PPD and Icon affected …
Toronto skyline

Canada’s biotech challenge

July 27, 2009 Research and Development Canada, Transition Therapeutics, biotech, funding

 The Niagara Falls are one of the wonders of the natural world, and every year millions of visitors from around …

AAIPharma sells development services unit

July 27, 2009 Manufacturing and Production, Research and Development AAI Pharma

US pharmaceutical services firm AAIPharma has sold its drug development division to a private equity firm in another example of …

BMS buys Medarex for $2.1 billion

July 24, 2009 Research and Development, Sales and Marketing BMS, MA, Medarex

Bristol-Myers Squibb is to spend $2.1 billion in buying Medarex, the human antibody drug discovery specialists. Princeton-based Medarex is best …
The Gateway to Local Adoption Series

Latest content